Gene Polymorphisms of Epidermal Growth Factor Receptor and its Downstream Effector, Interleukin-8, Predict Oxaliplatin Efficacy in Patients with Advanced Colorectal Cancer
- 1 July 2005
- journal article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 5 (2) , 124-131
- https://doi.org/10.3816/ccc.2005.n.025
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastasesEuropean Journal Of Cancer, 2002
- Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK familiesThorax, 2000
- Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non–Small-Cell Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitisArthritis & Rheumatism, 2000
- Epidermal growth factor-related peptides and their receptors in human malignanciesPublished by Elsevier ,2000
- The EGF receptor as central transducer of heterologous signalling systemsPublished by Elsevier ,1999
- Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1Journal of Biological Chemistry, 1999
- Coexpression of interleukin-8 receptors in head and neck squamous cell carcinomaThe American Journal of Surgery, 1997
- A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.Proceedings of the National Academy of Sciences, 1994
- EGF receptor in neoplasia and metastasisCancer and Metastasis Reviews, 1993